|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the US Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND
Background: Research conducted before genotyping was possible suggested that subjects heterozygous for the genetic mutation associated with hemochromatosis absorbed nonheme iron more efficiently than did control subjects when tested with a fortified meal. Heme-iron absorption in these subjects has not been reported.
Objective: We compared the absorption of heme and nonheme iron from minimally or highly fortified test meals between HFE C282Y-heterozygous and wild-type control subjects.
Design: After prospective genotyping of 256 healthy volunteers, 11 C282Y-heterozygous and 12 wild-type control subjects were recruited, and their iron absorption was compared by using a hamburger test meal with or without added iron and ascorbic acid. After retrospective genotyping of 103 participants in previous iron-absorption studies, 5 C282Y-heterozygous subjects were compared with 72 wild-type control subjects.
Results: HFE C282Y-heterozygous subjects did not differ significantly from wild-type control subjects in their absorption of either heme or nonheme iron from minimally or highly fortified test meals. No differences were detected in blood indexes of iron status (including serum ferritin, transferrin saturation, and non-transferrin-bound iron) or in blood lipids or transaminases, but heterozygotes had significantly greater, although normal, fasting glucose concentrations than did wild-type control subjects. Compound heterozygotes (those who had both HFE C282Y and H63D mutations) absorbed more nonheme (but not heme) iron from meals with high (but not low) iron bioavailability.
Conclusions: HFE C282Y-heterozygous subjects did not absorb dietary iron more efficiently, even when foods were highly fortified with iron from ferrous sulfate and ascorbic acid, than did control subjects. Iron fortification of foods should not pose an additional health risk to HFE C282Y heterozygotes.
Key Words: Nutrient-gene interactions nonheme-iron absorption heme-iron absorption diet iron bioavailability iron fortification hemochromatosis serum ferritin non-transferrin-bound iron glucose
Related articles in AJCN:
This article has been cited by other articles:
![]() |
J. R Hunt, C. A. Zito, and L. K Johnson Body iron excretion by healthy men and women Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1792 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. McCune Sex, Drugs, and 'Heavy Metal': Does Diet Also Matter in the Clinical Expression of Hereditary Hemochromatosis? Mayo Clin. Proc., May 1, 2008; 83(5): 526 - 528. [Full Text] [PDF] |
||||
![]() |
A.-L. M. Heath, M. A. Roe, S. L. Oyston, A. R. Gray, S. M. Williams, and S. J. Fairweather-Tait Blood Loss Is a Stronger Predictor of Iron Status in Men Than C282Y Heterozygosity or Diet J. Am. Coll. Nutr., February 1, 2008; 27(1): 158 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B Hadley, L. K Johnson, and J. R Hunt Iron absorption by healthy women is not associated with either serum or urinary prohepcidin Am. J. Clinical Nutrition, July 1, 2006; 84(1): 150 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qi, J. Meigs, J. E. Manson, J. Ma, D. Hunter, N. Rifai, and F. B. Hu HFE Genetic Variability, Body Iron Stores, and the Risk of Type 2 Diabetes in U.S. Women Diabetes, December 1, 2005; 54(12): 3567 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Hunt Absorption of iron from ferritin Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1178 - 1179. [Full Text] [PDF] |
||||
![]() |
M. A Roe, A.-L. M Heath, S. L Oyston, C. Macrow, J. A Hoogewerff, R. Foxall, J. R Dainty, G. Majsak-Newman, G. Willis, and S. J Fairweather-Tait Iron absorption in male C282Y heterozygotes Am. J. Clinical Nutrition, April 1, 2005; 81(4): 814 - 821. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |